Evaluation of Ceftaroline Fosamil Versus a Comparator in Adult Subjects With Community-acquired Bacterial Pneumonia (CABP) With Risk for Methicillin-resistant Staphylococcus Aureus
Public ClinicalTrials.gov record NCT01645735. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Multinational, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Ceftaroline Fosamil Versus Ceftriaxone Plus Vancomycin in Adult Subjects With Community-acquired Bacterial Pneumonia at Risk for Infection Due to Methicillin-resistant Staphylococcus Aureus
Study identification
- NCT ID
- NCT01645735
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Forest Laboratories
- Industry
- Enrollment
- 49 participants
Conditions and interventions
Conditions
Interventions
- Ceftaroline fosamil Drug
- Ceftriaxone plus vancomycin Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 30, 2012
- Primary completion
- Nov 30, 2013
- Completion
- Nov 30, 2013
- Last update posted
- Jan 31, 2016
2012 – 2013
United States locations
- U.S. sites
- 13
- U.S. states
- 12
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigational Site | Phoenix | Arizona | 85008 | — |
| Investigational Site | Sylmar | California | 91342 | — |
| Investigational Site | DeLand | Florida | 32720 | — |
| Investigational Site | Chicago | Illinois | 60611 | — |
| Investigational Site | Kansas City | Kansas | 66012 | — |
| Investigational Site | Royal Oak | Michigan | 48073 | — |
| Investigational Site | Minneapolis | Minnesota | 55145 | — |
| Investigational Site | St Louis | Missouri | 63110 | — |
| Investigational Site | Omaha | Nebraska | 68131 | — |
| Investigational Site | Laconia | New Hampshire | 03246 | — |
| Investigational Site | Columbus | Ohio | 43215 | — |
| Investigational Site | Lima | Ohio | 45801 | — |
| Investigational Site | Oklahoma City | Oklahoma | 73104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 18 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01645735, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 31, 2016 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01645735 live on ClinicalTrials.gov.